Thus, we designed this study to investigate the role of the microRNA-338-5p/WNT2B axis in regulating NPC pathogenesis, which not only broadened our knowledge in this field, but provided novel biomarkers for NPC diagnosis and treatment. Here, WNT2B is linked to nasopharyngeal carcinoma.